Comparative Analysis of Awareness Regarding Pharmacovigilance, Hemovigilance, and Materiovigilance among Medical Professionals in a Tertiary Care Hospital
Creators
- 1. Professor, Department of Pharmacology, Sri Venkateswara Medical College, Tirupati, Dr.YSRUHS, Andhra Pradesh, India
- 2. Associate Professor, Department of Pharmacology, Government Medical College, Kadapa, Dr.YSRUHS, Andhra Pradesh, India
- 3. Associate Professor, Department of Pharmacology, Government Medical College, Nandyal, Dr.YSRUHS, Andhra Pradesh, India
- 4. Assistant Professor, Department of Pharmacology, Government Medical College, Kadapa, Dr.YSRUHS, Andhra Pradesh, India
Description
Background: The importance of pharmacovigilance, hemovigilance, and materiovigilance in medical practice is undisputed, yet awareness of these areas among medical professionals varies. This study investigates the awareness levels of these three key vigilance systems among medical professionals in a tertiary care hospital. Methods: A cross-sectional survey was conducted among 100 medical professionals, including doctors, nurses, and allied health professionals. Data were collected using structured questionnaires and in-depth interviews, focusing on the awareness levels of pharmacovigilance, hemovigilance, and materiovigilance. Results: The study revealed that 70% of participants were aware of all three vigilance areas, with doctors showing the highest awareness (85%), followed by allied health professionals (65%) and nurses (60%). In pharmacovigilance, 60% of participants had a comprehensive understanding, while in hemovigilance and materiovigilance, the high awareness was 50% and 40%, respectively. Notably, experience and recent training significantly influenced awareness levels. Specialists and staff in related departments showed higher awareness compared to general practitioners. Conclusion: The overall awareness of pharmacovigilance, hemovigilance, and materiovigilance among medical professionals is encouraging but varies significantly across different professional roles and levels of experience. Continuous training and specialized education are crucial in enhancing awareness levels, particularly in less recognized areas like materiovigilance.
Abstract (English)
Background: The importance of pharmacovigilance, hemovigilance, and materiovigilance in medical practice is undisputed, yet awareness of these areas among medical professionals varies. This study investigates the awareness levels of these three key vigilance systems among medical professionals in a tertiary care hospital. Methods: A cross-sectional survey was conducted among 100 medical professionals, including doctors, nurses, and allied health professionals. Data were collected using structured questionnaires and in-depth interviews, focusing on the awareness levels of pharmacovigilance, hemovigilance, and materiovigilance. Results: The study revealed that 70% of participants were aware of all three vigilance areas, with doctors showing the highest awareness (85%), followed by allied health professionals (65%) and nurses (60%). In pharmacovigilance, 60% of participants had a comprehensive understanding, while in hemovigilance and materiovigilance, the high awareness was 50% and 40%, respectively. Notably, experience and recent training significantly influenced awareness levels. Specialists and staff in related departments showed higher awareness compared to general practitioners. Conclusion: The overall awareness of pharmacovigilance, hemovigilance, and materiovigilance among medical professionals is encouraging but varies significantly across different professional roles and levels of experience. Continuous training and specialized education are crucial in enhancing awareness levels, particularly in less recognized areas like materiovigilance.
Files
IJPCR,Vol16,Issue1,Article75.pdf
Files
(667.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:f5dec5abc2dfffed29256adb44b5ad4c
|
667.7 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-12-26
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue1,Article75.pdf
- Development Status
- Active
References
- 1. Meher BR, Padhy BM, Srinivasan A, Mohanty RR. Awareness, attitude, and practice of materiovigilance among medical professionals at a tertiary care institute of national importance: A cross-sectional study. Perspect Clin Res. 2022 Apr-Jun; 13(2):94-98. 2. Tripathy R, Das S, Das P, Mohakud NK, Das M. Adverse Drug Reactions in the Pediatric Population: Findings from the Adverse Drug Reaction Monitoring Center of a Teaching Hospital in Odisha (2015-2020). Cureus. 2021 Nov 9; 13(11):e19424. 3. Meher BR, Dash A. Reporting of adverse events related to medical devices: A singlecenter experience from a tertiary care institute of national importance in India. Indian J Pharmacol. 2023 Mar-Apr; 55(2):128-132.4. Aziz AA, Rogers S, Hassanien O, Shalaby L, Nagy M. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation. Per Med. 2022 Nov; 19(6):495-507. 5. Kalaiselvan V, Tripathi SK, Prakash J. Materiovigilance Programme of India: A scheme to assure cardiovascular devices safety surveillance. Indian Heart J. 2020 Jul-Aug; 72(4):316-318. 6. Hoda F, Verma R, Arshad M, Siddiqui AN, Khan MA, Akhtar M, Najmi AK. Materiovigilance: Concept, Structure and Emerging Perspective for Patient's Safety in India. Drug Res (Stuttg). 2020 Sep; 70(9):429-436. 7. Raghav MV, Geetha A, Purushotham VS, Mamatha K, Rajesh J, Raghuvanshi R, Kalaiselvan V, Shukla S, Hariharan V, Gowda BN. A cross-sectional analysis of medical device-associated adverse events with radiotherapy devices - A materiovigilance study. Indian J Pharmacol. 2023 May-Jun; 55(3):162-166. 8. Wood EM, Whitaker BI, Townsend M. Haemovigilance: Giving it our best SHOT! Vox Sang. 2023 Apr; 118(4):260-262. 9. Rana R, Veluri Kishore SR, Kaur G, Singh G, Kumar R. Ensuring Safe Transfusion Practices through Haemovigilance: India vis-a-vis Global Scenario. Curr Drug Saf. 2023; 18(4):474- 483. 10. Wood EM, Ang AL, Bisht A, Bolton-Maggs PH, Bokhorst AG, Flesland O, Land K, Wiersum-Osselton JC, Schipperus MR, Tiberghien P, Whitaker BI. International haemovigilance: what have we learned and what do we need to do next? Transfus Med. 2019 Aug; 29(4):221- 230. 11. Sudha R, Goel I, Katiyar P, Misra G, Roshan R, Sharma N, Sharma SK, Katiyar A. Haemovigilance in India during the COVID-19 pandemic. J Glob Health. 2023 Sep 22; 13:03030. 12. Salvo F, Micallef J, Lahouegue A, Chouchana L, Létinier L, Faillie JL, Pariente A. Will the future of pharmacovigilance be more automated? Expert Opin Drug Saf. 2023 Jul-Dec; 22(7):541-548. 13. Choudhury A, Singh PA, Bajwa N, Dash S, Bisht P. Pharmacovigilance of herbal medicines: Concerns and future prospects. J Ethnopharmacol. 2023 Jun 12; 309:116383. 14. Bechar H, Attjioui H, Mimouni H, Ismaili R, Tebaa A, Belahcen J, Rahali Y. Materiovigilance in health centers: The role of notifiers to ensure safer use of medical devices. Ann Pharm Fr. 2022 May; 80(3):301-311. 15. Salehi T, Seyedfatemi N, Mirzaee MS, Maleki M, Mardani A. Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review. Biomed Res Int. 2021 Apr 9; 2021:6630404. 16. Mulchandani R, Kakkar AK. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions. Int J Risk Saf Med. 2019;30(1):33-44. 17. Sidhu GS, Kumar J, Kumar D, Dey N, Ranjan G, Sinha T, Pal R. Knowledge and perception regarding adverse drug reactions among undergraduate medical students of Bihar, Eastern India. J Family Med Prim Care. 2023 Sep; 12(9):2082-2089. 18. Sivagourounadin K, Rajendran P, Ravichandran M. Knowledge, Attitude, and Practice of Materiovigilance among Nurses at a Tertiary Care Hospital in South India: A CrossSectional Study. J Pharm Bioallied Sci. 2022 Jul-Sep; 14(3):162-167. 19. Sharif MJH, Farrukh MJ, Khan FU, Khan Q, Ahmed SS, Kousar R, Ahmad T, Abid SMA, Ashfaq M, Khan SA. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan. Curr Med Res Opin. 2022 Apr; 38(4):595-605. 20. Adisa R, Omitogun TI. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res. 2019 Dec 3;19(1):926.